Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

Wall, S.J. van der; Lopes, R.D.; Aisenberg, J.; Reilly, P.; Ryn, J. van; Glund, S.; ... ; Huisman, M.V. (2019)

Article / Letter to editor

• atrial fibrillation
• dabigatran
• gastrointestinal hemorrhage
• idarucizumab

• All authors: Wall, S.J. van der; Lopes, R.D.; Aisenberg, J.; Reilly, P.; Ryn, J. van; Glund, S.; Elsaesser, A.; Klok, F.A.; Pollack, C.V.; Huisman, M.V.
• Date: 2019-02-05
• Journal: Circulation
• Volume: 139
• Issue: 6
• Pages: 748 - 756
• DOI: doi:10.1161/CIRCULATIONAHA.118.036710